These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8024823)

  • 41. [Late onset multiple sclerosis].
    Delalande S; De Seze J; Ferriby D; Stojkovic T; Vermersch P
    Rev Neurol (Paris); 2002 Nov; 158(11):1082-7. PubMed ID: 12451340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple sclerosis in Australia: prognostic factors.
    Hammond SR; McLeod JG; Macaskill P; English DR
    J Clin Neurosci; 2000 Jan; 7(1):16-9. PubMed ID: 10847644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.
    Bergamaschi R
    Expert Rev Neurother; 2006 Mar; 6(3):357-64. PubMed ID: 16533140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood-juvenile multiple sclerosis: clinical characteristics and treatment.
    Ghezzi A
    Expert Rev Neurother; 2005 May; 5(3):403-11. PubMed ID: 15938673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Can the prognosis of multiple sclerosis be predicted?].
    Moreau T; Confavreux C
    Pathol Biol (Paris); 2000 Mar; 48(2):132-8. PubMed ID: 10815289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognosis and factors that predict outcome in multiple sclerosis].
    Matsui M
    Nihon Rinsho; 2003 Aug; 61(8):1396-401. PubMed ID: 12962029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic factors in multiple sclerosis in a population-based series in Asturias].
    Uría DF; Menes BB; Calatayud MT; Arribas JM
    Neurologia; 1994 May; 9(5):182-7. PubMed ID: 8024823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors in multiple sclerosis.
    Bergamaschi R
    Int Rev Neurobiol; 2007; 79():423-47. PubMed ID: 17531853
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.